✦ LIBER ✦

Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma

✍ Scribed by Somerville, Laura; Bardelas, Jose; Viegas, Andrea; D’Andrea, Peter; Blogg, Martin; Peachey, Guy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Omalizumab Improves Patient-Reported Out

✍ Yang, W.H.; Georgiou, P.; Canvin, J.; Chen, C.; Peachey, G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Reductions In Oral Corticosteroid Use In

✍ Braunstahl, G.; Maykut, R.; Figliomeni, M.; Chen, C.; Peachey, G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Omalizumab in patients with allergic (Ig

✍ Kornmann, Oliver; Watz, Henrik; Fuhr, Rainard; Krug, Norbert; Erpenbeck, Veit J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Persistency of response to omalizumab th

✍ J. Bousquet; Z. Siergiejko; E. Świebocka; M. Humbert; K. F. Rabe; N. Smith; J. L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Omalizumab, an Anti-IgE Monoclonal Antib

✍ Hébert, J.; Rolli, M.; Gao, J.; Reisner, C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Omalizumab for the treatment of exacerba

✍ Lanier, Bob; Bridges, Tracy; Kulus, Marek; Taylor, Angel Fowler; Berhane, Indria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 355 KB